Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Application of ATRX in diagnosis and prognostic evaluation of glioma].

Zhonghua bing li xue za zhi = Chinese journal of pathology - 8 Oct 2017

Li Z, Piao Y S, Zhang L Y, Wang L M, Wang D D, Fu Y J, Cai Y N, Lu D H

Abstract excerpt

Objective: To investigate the diagnostic and prognostic implications of ATRX mutation and p53 mutation in patients with glioma. Methods: The clinicopathologic and molecular features of Chinese adult glioma patients, including diffuse and anaplastic astroastrocytoma with IDH mutation, oligodendroglioma and anaplastic oligodendroglioma with IDH mutation and 1p/19q co-deletion and diffuse astroastrocytoma with IDH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Genes, p53
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Oligodendroglioma

Share to Prognosis

Share to Tumor Suppressor Protein p53

Share to X-linked Nuclear Protein

Source

Identifiers

PMID: 29050070
DOI: 10.3760/cma.j.issn.0529-5807.2017.10.006

Genes

ATRX

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Application of ATRX in diagnosis and prognostic evaluation of glioma].PMID 29050070Read ↗

ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients.Semantic proximity Read ↗

Molecular Classification Defines 4 Prognostically Distinct Glioma Groups Irrespective of Diagnosis and GradeSemantic proximity Read ↗

The Role of ATRX in Glioma BiologySemantic proximity Read ↗

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas.Semantic proximity Read ↗

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.Semantic proximity Read ↗

Correlation between IDH, ATRX, and TERT promoter mutations in glioma.Semantic proximity Read ↗

Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosisSemantic proximity Read ↗

Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.Semantic proximity Read ↗

ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset.Semantic proximity Read ↗

Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas.Semantic proximity Read ↗

Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas.Semantic proximity Read ↗

The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.